SCHEMBL29506773

CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1C=NC=N1)NC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CS)NC(=O)CNC(=O)CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC1C=NC=N1)NC(=O)[C@H](CS)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](Cc1ccccc1)C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)O)C(C)C

nearest known ligand 0.64

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	CXCR4	P61073	9/20	0.64

▸	C5AR1	P21730	1/20	0.59

▸	NPY1R	P25929	1/20	0.58

▸	NPY2R	P49146	1/20	0.58

▸	NPY4R	P50391	1/20	0.58

▸	NPY5R	Q15761	1/20	0.58

▸	CALCA	P06881	1/20	0.57

▸	GLP1R	P43220	2/20	0.56

▸	PTH1R	Q03431	4/20	0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL29851285	0.87	CXCR4 (0.64)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30887982	0.86	NPY1R (0.70)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30669427	0.86	NPY2R (0.69)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182564	0.85	NPY1R (0.70)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL29880262	0.85	PTH1R (0.63)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL30432210	0.84	C5AR1 (0.66)	CXCR4C5AR1NPY1RNPY2RNPY4R
SCHEMBL31182694	0.84	CXCR4 (0.71)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182921	0.84	NPY2R (0.76)	CXCR4NPY1RNPY2RNPY4RNPY5R
SCHEMBL31182507	0.84	NPY1R (0.72)	CXCR4C5AR1NPY1RNPY2RNPY4R
SCHEMBL31182815	0.84	NPY2R (0.73)	CXCR4NPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-3574909-B1	POLYELECTROLYTE MULTILAYER COMPRISING SILVER FOR WOUND HEALING	IMBED BIOSCIENCES INC (US)	2026-03-04	—	—	EP	disclosed
US-20260000805-A1	METHODS AND COMPOSITIONS FOR WOUND HEALING	IMBED BIOSCIENCES INC (US)	2026-01-01	—	—	US	disclosed
US-12409247-B2	Methods and compositions for wound healing	IMBED BIOSCIENCES INC. (US)	2025-09-09	—	—	US	disclosed
US-20250171776-A1	NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY	SAREPTA THERAPEUTICS, INC. (US)	2025-05-29	—	—	US	disclosed
WO-2025030099-A1	NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY	SAREPTA THERAPEUTICS, INC. (US)	2025-02-06	—	—	WO	disclosed
CN-112703185-B	Thiocycloheptyne derivatives and uses thereof	克里斯特递送有限公司	2024-12-27	—	—	CN	disclosed
US-12054471-B2	Thiocycloheptyne derivatives and their use	CRISTAL DELIVERY B.V. (NL)	2024-08-06	—	—	US	disclosed
US-20240009342-A1	METHODS AND COMPOSITIONS FOR WOUND HEALING	IMBED BIOSCIENCES INC.	2024-01-11	—	—	US	disclosed
EP-4289910-A2	METHODS AND COMPOSITIONS FOR WOUND HEALING	Imbed Biosciences, Inc. (US)	2023-12-13	—	—	EP	disclosed
EP-3490622-B1	METHODS AND COMPOSITIONS FOR WOUND HEALING	IMBED BIOSCIENCES INC (US)	2023-09-06	—	—	EP	disclosed
US-11554194-B2	Methods and compositions for wound healing	IMBED BIOSCIENCES INC. (US)	2023-01-17	—	—	US	disclosed
EP-3995158-A1	METHODS AND COMPOSITIONS FOR WOUND HEALING	Imbed Biosciences, Inc. (US)	2022-05-11	—	—	EP	disclosed
CN-111925449-B	Recombinant CHO cell strain expressing chicken VP2 and chicken GAL-1 fusion protein and construction method and application thereof	浙江鼎持生物制品有限公司	2022-02-01	—	—	CN	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20260000805-A1	METHODS AND COMPOSITIONS FOR WOUND HEALING	PCNA, ARG1, PLOD3	CXCR4 3298/4885C5AR1 1255/4885NPY1R 4399/4885
US-20250171776-A1	NON-CANONICAL CELL-PENETRATING PEPTIDES FOR ANTISENSE OLIGOMER DELIVERY	MYOF, TNNC1, MTPN	CXCR4 2331/4885C5AR1 704/4885NPY1R 3454/4885
US-12054471-B2	Thiocycloheptyne derivatives and their use	CYP7A1, CYP3A5, ABCB1	CXCR4 3037/4885C5AR1 1048/4885NPY1R 3427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.